- Symbol
- AVCN
- Segment MIC
- XTSE
- Trading currency
- CAD
XTSE:AVCN — listed on Toronto Stock Exchange
Avicanna Inc. is a biopharmaceutical company focused on the research, development, and commercialization of cannabinoid-based products for the medical and pharmaceutical markets. The company operates four business units: medical cannabis products, a pharmaceutical pipeline, a medical cannabis care platform, and active pharmaceutical ingredients. Avicanna serves various international markets with over fifty proprietary formulations, including oral, topical, and transdermal products, and aims to address clinical indications such as sleep disorders, pain management, and mental health through its drug candidates. The company is headquartered in Toronto, Canada, and has established a scientific platform that supports its product development and commercialization efforts.